Regulating mGluR5 expression in the cells that affect the tumor growth by delivering siRNA would be beneficial, since we can improve target-specific treatment and avoid cancer recurrence and tumor progression that is caused by drug resistance occurring in the tumor microenvironment. The gene discussed is GRM5; the disease is cancer.